⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRA News
Natera, Inc. Common Stock
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
businesswire.com
NTRA
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
businesswire.com
NTRA
大腸がんを対象に、Signatera診断システムTMが薬事承認を取得
businesswire.com
NTRA
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
businesswire.com
NTRA
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
businesswire.com
NTRA
Form 8-K/A
sec.gov
NTRA
Form 8-K
sec.gov
NTRA
Form 8-K
sec.gov
NTRA
Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
businesswire.com
NTRA
Liquid Biopsy Market to Surpass USD 36.78 Billion by 2035 as Precision Oncology and Cancer Diagnostics Drive Growth – SNS Insider
globenewswire.com
GH
NTRA